In English | En español
Questions About Cancer? 1-800-4-CANCER

Featured Clinical Trials

Highlighted NCI-Supported Cancer Studies < Back to Main

Page Options

  • Print This Page
  • Email This Document

Search Featured Trials

Prostate Cancer - Featured Clinical Trials

The following list shows Featured Clinical Trials for a specific type of cancer. You may also want to view:

  • Blocking DNA Repair in Advanced BRCA-Mutated Cancer
    (Posted: 01/31/2014) - In this trial, patients with relapsed or refractory advanced cancer and confirmed BRCA mutations who have not previously been treated with a PARP inhibitor will be given BMN 673 by mouth once a day in 28-day cycles.
  • MRI-Guided Focal Laser Therapy for Low-risk Prostate Cancer
    (Posted: 07/10/2012) - In this pilot study, men diagnosed with or suspected of having low-risk prostate cancer will undergo advanced MRI techniques to guide a biopsy to the tumor area; subsequently, they will be treated using MRI-guided focal laser ablation therapy to only that area of the prostate.
  • Inhibiting Tumor Angiogenesis in Metastatic Hormone-Refractory Prostate Cancer
    (Posted: 04/05/2011) - In this NIH Clinical Center study, researchers will test whether treatment with a novel monoclonal antibody, TRC105, that targets a protein highly expressed on the surface of tumor blood vessels improves the outcome of men with metastatic castration-resistant prostate cancer.
  • Combining Vaccine and Antiandrogen Therapy for Prostate Cancer
    (Posted: 09/21/2010) - In this clinical trial, men with castration-resistant, nonmetastatic prostate cancer who are undergoing androgen deprivation therapy will be randomly assigned to undergo antiandrogen treatment with the FDA-approved drug flutamide with or without the addition of a PSA-targeting vaccine called PROSTVAC/PSA-TRICOM.
  • Inhibiting Angiogenesis in Metastatic Castration-Resistant Prostate Cancer
    (Posted: 06/29/2010) - In this trial, patients with metastatic castration-resistant prostate cancer who have received no treatment for metastatic disease will be treated with docetaxel, prednisone, bevacizumab, and lenalidomide.
1 2 3 4 5  Next >